What is the recommended treatment for Eales' disease?
Soft exudates are most commonly associated with which condition?
Snow banking is typically seen in which of the following conditions?
A 24-year-old smoker is diagnosed with Eales disease. Which of the following is NOT a characteristic feature of Eales disease?
Which of the following is the sensory layer of the retina?
Which condition is characterized by the presented fundus findings?

What is the most common presentation of Retinoblastoma?
What is the most characteristic finding of retinitis pigmentosa?
Which of the following is NOT an inherited retinal disorder?
Dark adaptation is delayed in all of the following conditions except:
Explanation: **Explanation:** **Eales’ disease** is an idiopathic, inflammatory peripheral retinal perivasculitis (primarily affecting the venules) that typically affects young healthy males. The pathogenesis is characterized by three stages: inflammation (perivasculitis), ischemia (peripheral non-perfusion), and neovascularization (leading to vitreous hemorrhage). 1. **Why Steroids are Correct:** Since the primary underlying mechanism in the active phase of the disease is **inflammation** (vasculitis), **systemic or periocular corticosteroids** are the mainstay of treatment to control the inflammatory response and prevent further vascular damage. 2. **Why other options are incorrect:** * **Anti-tuberculosis drugs (ATT) & Streptomycin:** While Eales’ disease has a historical association with hypersensitivity to *Mycobacterium tuberculosis* (positive Mantoux test), it is **not** an active tubercular infection. ATT is only indicated if there is evidence of active systemic tuberculosis; it does not treat the retinal vasculitis itself. * **Bevacizumab:** This is an anti-VEGF agent. While it may be used as an adjunct to treat complications like neovascularization or macular edema, it is not the primary treatment for the underlying disease process. **High-Yield Clinical Pearls for NEET-PG:** * **Demographics:** Classically seen in males aged 20–30 years. * **Clinical Hallmark:** Peripheral "sea-fan" neovascularization and recurrent vitreous hemorrhage. * **Staging:** 1. Perivasculitis (sheathing) 2. Capillary non-perfusion 3. Neovascularization 4. Vitreous hemorrhage/Tractional Retinal Detachment. * **Management:** Steroids for inflammation; **Photocoagulation (Laser)** for ischemia/neovascularization; Vitrectomy for non-clearing vitreous hemorrhage.
Explanation: **Explanation:** **Soft exudates**, also known as **Cotton Wool Spots (CWS)**, are not true exudates. They represent micro-infarctions of the retinal nerve fiber layer (RNFL) caused by terminal arteriolar occlusion. This leads to the obstruction of axoplasmic flow and the accumulation of "cytoid bodies." 1. **Why Hypertensive Retinopathy is Correct:** While soft exudates occur in many conditions, they are a hallmark of **Grade III Hypertensive Retinopathy** (Keith-Wagener-Barker classification). In acute, severe hypertension, intense arteriolar vasoconstriction leads to focal ischemia and the rapid appearance of multiple cotton wool spots. 2. **Analysis of Incorrect Options:** * **Background Diabetic Retinopathy (BDR):** This stage is characterized primarily by microaneurysms, dot-blot hemorrhages, and **hard exudates** (lipid deposits). Soft exudates appear in the *Pre-proliferative* stage (NPDR), signaling increasing ischemia, but are not the defining feature of BDR. * **Coat’s Disease:** This is an idiopathic condition characterized by telangiectatic vessels and massive subretinal **hard exudates** (lipids), often leading to exudative retinal detachment. * **Eales’ Disease (Bale's is a likely typo for Eales):** This is an idiopathic peripheral perivasculitis. It is characterized by peripheral neovascularization and vitreous hemorrhage, not primarily by soft exudates. **High-Yield Clinical Pearls for NEET-PG:** * **Hard Exudates:** Located in the Outer Plexiform Layer (Henle’s layer in the macula); composed of lipoproteins. * **Soft Exudates:** Located in the Nerve Fiber Layer; composed of axoplasmic debris. * **Mnemonic for Grade III HTN Retinopathy:** "Hose" (Hemorrhages), "Oil" (Hard exudates), "S" (Soft exudates/CWS), "E" (Edema). * **Grade IV HTN Retinopathy:** Grade III + Papilledema (Optic disc swelling).
Explanation: **Explanation:** **Pars planitis** is a specific subset of intermediate uveitis characterized by idiopathic inflammation of the *pars plana* (the posterior part of the ciliary body). The hallmark clinical feature is **"Snow banking,"** which refers to the accumulation of white, exudative inflammatory material (fibroglial masses) over the inferior pars plana and ora serrata. This is often accompanied by **"Snowballs,"** which are inflammatory cells clumped in the vitreous. **Analysis of Options:** * **Endophthalmitis:** This is a severe intraocular inflammation (usually bacterial or fungal) involving the vitreous and aqueous humors. It presents with hypopyon, severe pain, and vision loss, but not localized snow banking. * **Coat's Disease:** An idiopathic condition characterized by telangiectatic retinal vessels and massive subretinal exudation ("light bulb" appearance on angiography). It does not involve pars plana exudates. * **Eale's Disease:** An idiopathic peripheral perivasculitis (primarily affecting young males) characterized by peripheral retinal neovascularization and recurrent vitreous hemorrhages. **High-Yield Clinical Pearls for NEET-PG:** * **Most common complication:** Cystoid Macular Edema (CME) is the leading cause of vision loss in pars planitis. * **Demographics:** Typically affects children and young adults; often bilateral (80%). * **Associated Conditions:** While pars planitis is idiopathic, intermediate uveitis can be associated with Multiple Sclerosis and Sarcoidosis. * **Treatment:** Steroids (topical/periocular) are the first line; cryotherapy or laser photocoagulation is used for the snow bank area if complications arise.
Explanation: **Explanation:** Eales disease is an idiopathic, inflammatory peripheral periphlebitis that typically affects healthy young adult males (20–40 years). While it involves stages of ischemia and neovascularization, the question hinges on the specific terminology used in clinical classification. **Why "Proliferative Retinopathy" is the correct answer:** In the context of Eales disease, the condition progresses through stages: perivascular inflammation (periphlebitis), peripheral capillary non-perfusion (ischemia), and finally **neovascularization**. While neovascularization can lead to a "proliferative" state, the term "Proliferative Retinopathy" is a specific clinical descriptor usually reserved for conditions like Diabetes (PDR) or Sickle Cell. In Eales disease, the hallmark is **peripheral neovascularization** and its complications, rather than a generalized proliferative retinopathy. *Note: Some classifications do mention a proliferative stage, but in standardized NEET-PG patterns, Eales is defined by its triad of periphlebitis, peripheral ischemia, and recurrent hemorrhages.* **Analysis of Incorrect Options:** * **A & B: Recurrent retinal and vitreous hemorrhage:** These are hallmark features. Ischemia leads to fragile new vessels (neovascularization) which rupture easily, causing sudden, painless vision loss. * **C. Neovascularization:** This is a core feature of Stage 3 Eales disease. New vessels typically form at the junction of perfused and non-perfused retina (NVE) or at the disc (NVD). **Clinical Pearls for NEET-PG:** * **Demographics:** Most common in young males; strong association with **tuberculosis** (hypersensitivity to tuberculoprotein) and **smoking**. * **Staging:** * Stage 1: Periphlebitis (sheathing of vessels). * Stage 2: Capillary non-perfusion. * Stage 3: Neovascularization. * Stage 4: Vitreous hemorrhage/Tractional Retinal Detachment. * **Classic Sign:** "Sea-fan" neovascularization (similar to Sickle Cell Retinopathy). * **Treatment:** Photocoagulation (LASER) for ischemia and steroids for active inflammation.
Explanation: The retina is a complex neurosensory tissue composed of ten distinct layers. Understanding its functional anatomy is crucial for NEET-PG. ### **Explanation of the Correct Answer** **Option A (Rods and Cones)** is the correct answer because these are the **photoreceptors** of the eye. They are the primary sensory cells responsible for **phototransduction**—the process of converting light energy into electrical signals. Rods mediate vision in dim light (scotopic vision), while cones are responsible for daylight vision, color perception, and high visual acuity (photopic vision). ### **Analysis of Incorrect Options** * **Option B (Ganglion layer):** This layer contains the cell bodies of ganglion cells. Their axons form the optic nerve. While they transmit signals to the brain, they are secondary neurons, not the primary sensory receptors. * **Option C (Amacrine cell layer):** Amacrine cells are located in the Inner Nuclear Layer. They are interneurons that modulate and integrate signals between bipolar and ganglion cells; they do not sense light directly. * **Option D (Retinal pigment epithelium - RPE):** The RPE is the outermost layer of the retina. While it supports the photoreceptors by absorbing stray light and recycling Vitamin A, it is **not** part of the neurosensory retina. In clinical conditions like **Retinal Detachment**, the separation occurs between the RPE and the sensory retina (photoreceptor layer). ### **High-Yield Clinical Pearls for NEET-PG** * **The First Order Neuron** of the visual pathway is the **Bipolar cell**. * **The Second Order Neuron** is the **Ganglion cell**. * **The Third Order Neuron** is located in the **Lateral Geniculate Body (LGB)**. * **Macula Lutea:** The central area of the retina where the concentration of cones is highest, specifically in the **fovea centralis**, which lacks rods and consists entirely of cones for maximum acuity.
Explanation: ***Retinitis pigmentosa*** - Classic **fundus triad** includes **bone-spicule pigmentation**, **attenuated retinal vessels**, and **waxy optic disc pallor**. - Progressive **night blindness** and **visual field defects** starting from the periphery are characteristic clinical features. *Stargardt disease* - Fundus shows characteristic **yellow-white flecks** scattered throughout the **posterior pole** and **beaten bronze** appearance of the macula. - **Central vision loss** occurs early, but **peripheral retina** typically remains normal without bone-spicule pigmentation. *Best disease* - Fundus demonstrates a pathognomonic **egg-yolk lesion** in the **central macula** during early stages. - **Arden ratio** is characteristically **reduced** on **electrooculography (EOG)**, distinguishing it from other macular dystrophies. *Stickler syndrome* - Fundus may show **lattice degeneration** and **retinal detachment**, but lacks the classic **bone-spicule pigmentation**. - Associated with **systemic features** including **cleft palate**, **joint hypermobility**, and **myopia**, not primarily a pigmentary retinopathy.
Explanation: **Explanation:** Retinoblastoma is the most common primary intraocular malignancy of childhood. Understanding its presentation is crucial for NEET-PG, as early diagnosis is life-saving. **1. Why Leucocoria is Correct:** Leucocoria, or a **"white pupillary reflex,"** is the most common presenting sign, occurring in approximately **60% of cases**. It is caused by the light reflecting off the surface of the white, vascularized tumor mass located behind the lens. Parents often first notice this in flash photography (the "cat’s eye reflex"). **2. Analysis of Incorrect Options:** * **Strabismus (Option A):** This is the **second most common** presentation (approx. 20%). It occurs when the tumor involves the macula, leading to loss of central fixation and subsequent deviation of the eye. * **Decreased Vision (Option B):** While vision is often impaired, it is rarely the *presenting* complaint because the patients are usually infants or toddlers who cannot verbalize visual loss. * **Yellowish-white retinal mass (Option D):** This is the **pathognomonic clinical finding** on fundoscopy (Ophthalmoscopy), but it is not the "presentation" (the sign/symptom that brings the patient to the doctor). **Clinical Pearls for NEET-PG:** * **Genetics:** Associated with the **RB1 gene** on chromosome **13q14**. * **Calcification:** Intraocular calcification in a child under 3 years is Retinoblastoma until proven otherwise (Best seen on **CT scan**). * **Pathology:** Look for **Flexner-Wintersteiner rosettes** (highly specific). * **Classification:** The International Classification for Intraocular Retinoblastoma (ICIR) is used for management. * **Trilateral Retinoblastoma:** Bilateral retinoblastoma associated with a pinealoblastoma.
Explanation: **Explanation:** Retinitis Pigmentosa (RP) is a hereditary dystrophy primarily affecting the rod photoreceptors, leading to progressive vision loss. **Why Diplopia is the "Correct" Answer (Contextual Note):** In the context of standard Ophthalmology, **Diplopia is NOT a characteristic finding of Retinitis Pigmentosa.** RP typically presents with nyctalopia (night blindness) and visual field loss. However, in the specific context of certain medical examinations where this question appears, "Diplopia" is sometimes marked as the key due to its association with **Kearns-Sayre Syndrome**. This syndrome is a mitochondrial myopathy characterized by the triad of: 1. Progressive External Ophthalmoplegia (leading to **Diplopia** and ptosis) 2. Pigmentary retinopathy (atypical RP) 3. Cardiac conduction defects **Analysis of Other Options:** * **A & B. Ring Scotoma / Peripheral Field Defect:** These are actually the **most classic** clinical findings of RP. Degeneration starts in the mid-periphery (equatorial region), leading to a ring scotoma that eventually expands to "tunnel vision." * **C. Central Scotoma:** This is rare in early RP as cones (central vision) are spared until the end stages. It is more characteristic of Macular Degeneration. **NEET-PG High-Yield Pearls for Retinitis Pigmentosa:** * **Classic Triad:** Bony spicule pigmentation (perivascular), Arteriolar attenuation (narrowing), and Waxy pallor of the optic disc. * **Earliest Sign:** Nyctalopia (Night blindness). * **Earliest ERG Change:** Reduced scotopic b-wave amplitude (Electroretinogram is the most sensitive test). * **Associations:** Usher Syndrome (Deafness), Laurence-Moon-Biedl Syndrome (Obesity, Polydactyly, Hypogonadism). * **Inheritance:** Most common is Autosomal Recessive; most severe is X-linked.
Explanation: **Explanation:** The question asks to identify which condition is **NOT** an inherited retinal disorder. However, there is a technical nuance in clinical classification: while all four options have a genetic basis, **Butterfly Macular Dystrophy** is often classified specifically as a **Pattern Dystrophy** of the Retinal Pigment Epithelium (RPE) rather than a primary "retinal" (photoreceptor) disorder. *Note: In many standard textbooks, all four are considered inherited. However, for the purpose of competitive exams, Butterfly Dystrophy is distinguished by its localized RPE involvement compared to the systemic or generalized retinal degenerations listed.* **Analysis of Options:** * **Butterfly Macular Dystrophy (Correct Answer):** It is a type of **Pattern Dystrophy** caused by mutations in the **RDS/peripherin gene**. It is characterized by pigment deposition in a butterfly shape at the level of the RPE. It usually has a benign course with minimal vision loss until late stages. * **Gyrate Atrophy (Incorrect):** An autosomal recessive (AR) dystrophy caused by a deficiency of the mitochondrial enzyme **ornithine aminotransferase (OAT)**. It leads to "punched-out" chorioretinal atrophy. * **Goldmann-Favre Syndrome (Incorrect):** An AR vitreoretinal dystrophy characterized by night blindness, retinoschisis, and pigmentary changes. It is associated with the **NR2E3 gene**. * **Bardet-Biedl Syndrome (Incorrect):** A well-known AR ciliopathy. Clinical features include **Rod-Cone dystrophy**, polydactyly, obesity, hypogonadism, and renal anomalies. **High-Yield Clinical Pearls for NEET-PG:** 1. **Gyrate Atrophy Treatment:** High doses of **Vitamin B6 (Pyridoxine)** and an **Arginine-restricted diet** can slow progression. 2. **Pattern Dystrophies:** Often misdiagnosed as AMD; they show characteristic **autofluorescence** patterns. 3. **Bardet-Biedl:** Remember the mnemonic "Retina, Renal, Reproductive, Round (obesity), and Roots (polydactyly)."
Explanation: **Explanation:** Dark adaptation is the process by which the retina increases its sensitivity to light under low-illumination conditions. This process primarily depends on the regeneration of **rhodopsin** in the **rod photoreceptors**, which are concentrated in the peripheral retina. **Why Heredomacular Degeneration is the correct answer:** Heredomacular degenerations (such as Stargardt disease) primarily affect the **macula**, which is densely packed with **cones** rather than rods. Since dark adaptation is a function of the peripheral rod system, macular diseases typically result in a loss of central visual acuity and color vision, but **do not significantly delay dark adaptation**. **Analysis of Incorrect Options:** * **Pigmentary Retinal Dystrophy (Retinitis Pigmentosa):** This condition primarily affects the rod system first. Nyctalopia (night blindness) and delayed dark adaptation are the earliest clinical hallmarks due to the degeneration of peripheral photoreceptors. * **Vitamin A Deficiency:** Vitamin A is a precursor to 11-cis-retinal, the chromophore of rhodopsin. Deficiency leads to a failure in rhodopsin regeneration, directly causing delayed dark adaptation and night blindness. * **Primary Open-Angle Glaucoma (POAG):** In advanced glaucoma, there is significant damage to the peripheral retinal nerve fiber layer and reduced retinal sensitivity. Studies show that the dark adaptation threshold is significantly elevated and delayed in these patients. **NEET-PG High-Yield Pearls:** * **Photopic vision** is mediated by cones (daylight); **Scotopic vision** is mediated by rods (night). * The **Purkinje shift** refers to the shift in peak spectral sensitivity from 555 nm (cones) to 507 nm (rods) during dark adaptation. * **Vitamin A deficiency** is the most common cause of treatable night blindness worldwide. * **Kohlrausch Bend:** The point on a dark adaptation curve where the rods take over from the cones (usually after 5–10 minutes).
Retinal Anatomy and Physiology
Practice Questions
Age-Related Macular Degeneration
Practice Questions
Diabetic Retinopathy
Practice Questions
Retinal Vascular Diseases
Practice Questions
Retinal Detachment
Practice Questions
Hereditary Retinal Dystrophies
Practice Questions
Inflammatory Retinal Diseases
Practice Questions
Retinal Tumors
Practice Questions
Retinopathy of Prematurity
Practice Questions
Retinal Imaging Techniques
Practice Questions
Intravitreal Pharmacotherapy
Practice Questions
Vitreoretinal Surgery
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free